Navigating the Future of Liver Health: Spotlight on Hepatitis at the 16th World Gastroenterology Conference
The global landscape of hepatology is shifting. While we have made monumental strides in antiviral therapies and vaccination programs, Hepatitis remains one of the most significant public health challenges of our time. As we look toward the 16th World Gastroenterology, IBD, Hepatology Conference & Exhibition —taking place from December 10-11, 2026, in Kuala Lumpur, Malaysia —one area stands out as a pillar of the scientific program: Track 3: Hepatitis. Why Hepatitis Remains a Global Priority According to the World Health Organization, millions of people worldwide are living with chronic viral hepatitis, many of whom remain undiagnosed. The goal of eliminating hepatitis by 2030 is ambitious, and achieving it requires a synergy of clinical innovation, public policy, and frontline medical expertise. What to Expect in Track 3 Track 3 is dedicated to the latest breakthroughs in the prevention, diagnosis, and treatment of viral and non-viral hepatitis. Whether you are ...